The anti von willebrand factor aptamer ARC1779 increases platelet counts in a patient with familial thrombotic thrombocytopenic purpura (TTP)

被引：0
|
作者：
Firbas, C. [1 ]
Jilma, B. [1 ]
Gilbert, J. C. [2 ]
Schranz, S. [1 ]
Knoebl, P. [3 ]
机构：
[1] Med Univ Vienna, Clin Pharmacol, Vienna, Austria
[2] Archemix Corp, Clin Dev, Cambridge, MA USA
[3] Med Univ Vienna, Div Haematol & Haemostasis, Internal Med 1, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC-WE-011
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [1] PROOF OF CONCEPT FOR THE ANTI VON WILLEBRAND FACTOR APTAMER ARC1779 IN A PATIENT WITH FAMILIAL THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
    Hobl, E. -L
    Gorczyca, M.
    Jilma, B.
    Gilbert, J.
    Hutabarat, R.
    Knoebl, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 64 - 65
  • [2] Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura
    Knoebl, Paul
    Jilma, Bernd
    Gilbert, James C.
    Hutabarat, Renta M.
    Wagner, Patricia G.
    Jilma-Stohlawetz, Petra
    TRANSFUSION, 2009, 49 (10) : 2181 - 2185
  • [3] Safety, pharmacokinetics and pharmacodynamics of the anti von willebrand factor aptamer ARC1779 in patients with acute thrombotic thrombocytopenic purpura (TTP)
    Jilma, B.
    Jilma, P.
    Gilbert, J. C.
    Hutabarat, R.
    Siller, J.
    Spiel, A.
    Gorczyca, M.
    Knoebl, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 59 - 59
  • [4] Anti Von Willebrand Factor Aptamer ARC 1779 for Refractory Thrombotic Thrombocytopenic Purpura
    Firbas, Christa
    Jilma, Bernd
    Wagner, Patricia G.
    Hutabarat, Renta
    Schaub, Robert G.
    Gilbert, James C.
    Knoebl, Paul
    BLOOD, 2008, 112 (11) : 801 - 802
  • [5] Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
    Jilina-Stohlawetz, Petra
    Gorczyca, Monika E.
    Jilma, Bernd
    Siller-Matula, Jolanta
    Gilbert, James C.
    Knoebl, Paul
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (03) : 545 - 552
  • [6] The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo
    Mayr, Florian B.
    Knoebl, Paul
    Jilma, Bernd
    Siller-Matula, Jolanta M.
    Wagner, Patricia G.
    Schaub, Robert G.
    Gilbert, James C.
    Jilma-Stohlawetz, Petra
    TRANSFUSION, 2010, 50 (05) : 1079 - 1087
  • [7] The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease
    Jilma-Stohlawetz, Petra
    Knoebl, Paul
    Gilbert, James C.
    Jilma, Bernd
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (02) : 284 - 290
  • [8] The aptamer ARC1779 potently and specifically inhibits the excessive von Willebrand factor (vWF) activity and vWF-mediated ex vivo platelet function of patients with thrombotic thrombocytopenic purpura (TTP)
    Jilma, Bernd
    Mayr, Florian B.
    Knoebl, Paul
    Spiel, Alexander O.
    Mertino, Patricia G.
    Schaub, Robert
    Gilbert, James C.
    BLOOD, 2007, 110 (11) : 89A - 89A
  • [9] A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura
    Jilma-Stohlawetz, Petra
    Gilbert, James C.
    Gorczyca, Monika E.
    Knoebl, Paul
    Jilma, Bernd
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) : 539 - 547
  • [10] PROOF OF CONCEPT FOR THE ANTI VON WILLEBRAND FACTOR APTAMER IN PATIENTS WITH ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
    Hobl, E. -L
    Jilma, P.
    Gilbert, J. C.
    Hutabarat, R.
    Gorczyca, M.
    Knoebl, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 64 - 64
12345